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Laboratory diagnosis of human respiratory syncytial virus (hRSV) infections has traditionally been per-
formed by virus isolation in cell culture and the direct fluorescent-antibody assay (DFA). Reverse transcriptase
PCR (RT-PCR) is now recognized as a sensitive and specific alternative for detection of hRSV in respiratory
samples. Using the LightCycler instrument, we developed a rapid RT-PCR assay for the detection of hRSV (the
LC-RT-PCR) with a pair of hybridization probes that target the hRSV L gene. In the present study, 190
nasopharyngeal aspirate samples from patients with clinically recognized respiratory tract infections were
examined for hRSV. The results were then compared to the results obtained with a testing algorithm that
combined DFA and a culture-augmented DFA (CA-DFA) assay developed in our laboratory. hRSV was detected
in 77 (41%) specimens by LC-RT-PCR and in 75 (39%) specimens by the combination of DFA and CA-DFA.
All specimens that were positive by the DFA and CA-DFA testing algorithm were positive by the LC-RT-PCR.
The presence of hRSV RNA in the two additional LC-RT-PCR-positive specimens was confirmed by a conven-
tional RT-PCR method that targets the hRSV N gene. The sensitivity of LC-RT-PCR was 50 PFU/ml; and this,
together with its high specificity and rapid turnaround time, makes the LC-RT-PCR suitable for the detection
of hRSV in clinical specimens.
Human respiratory syncytial virus (hRSV) is one of the
major causes of viral respiratory tract disease in young children
and infants (23). Annually, it causes an estimated 1 million
deaths worldwide, primarily in children younger than 5 years of
age (9). Furthermore, hRSV remains the most common cause
of bronchiolitis in infants, with up to 10% of those infected
requiring specialized pediatric care (20, 26). Among infants in
the United States it is estimated that hRSV is responsible for
90,000 hospitalizations for bronchiolitis and US$2.25 billion in
health care costs each year (24, 25). In adults hRSV infection
usually results in a milder form of disease and often remains
undiagnosed (12). However, in immunocompromised and el-
derly patients, hRSV infection can lead to more serious clinical
manifestations (4, 6). Virus isolation by cell culture and direct
fluorescent-antibody assay (DFA) staining with monoclonal
antibodies are the most commonly used laboratory techniques
for the detection of hRSV infection, yet both of these methods
have significant limitations. Compared to cell culture and re-
verse transcriptase PCR (RT-PCR), DFA lacks sensitivity, is
subjective, and is dependent on the quality and presence of
appropriately infected cells (30). Although cell culture is more
sensitive than DFA, it requires specimens to be transported
and stored under ideal conditions, and the prolonged turn-
around time required to obtain results further diminishes its
usefulness in patient management (22).
In recent years RT-PCR has proved to be a highly sensitive
and specific method for the diagnosis of hRSV infections (1, 7,
18, 19). Unlike DFA and cell culture, the results of RT-PCR
are not significantly affected by the loss of viability of the virus
during specimen transport or storage and RT-PCR does do not
require the presence of intact, infected cells within the speci-
men. RT-PCR is therefore ideally suited for the detection of
hRSV. However, although clinical laboratories have shown an
increasing tendency to adopt PCR protocols as part of their
testing algorithms, the routine implementation of conventional
PCR technology also has limitations. These include the poten-
tial for PCR product carryover contamination and technically
cumbersome PCR product detection methods (5, 29). Some of
these limitations are overcome by real-time PCR instrumenta-
tion, which is the latest advance in nucleic acid amplification
and detection technology.
In this study we developed a real-time RT-PCR assay for the
detection of hRSV using the LightCycler instrument (Roche
Diagnostics, Sydney, Australia). This technology applies fluo-
rescence resonance energy transfer (FRET) to two fluoro-
phore-labeled hybridization probes during the continuous
monitoring of amplicon development in the amplification pro-
cess (31). Using the LightCycler RT-PCR assay (the LC-RT-
PCR), we examined 190 nasopharyngeal aspirate (NPA) spec-
imens from patients with respiratory infections for the
presence of hRSV. The data obtained by this assay were com-
pared with the results obtained by a conventional PCR and a
testing algorithm that combined DFA and culture-augmented
DFA (CA-DFA).
MATERIALS AND METHODS
Patient specimens. NPA specimens (n  190) from patients with respiratory
disease that were submitted to our hospital for the detection of respiratory
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viruses by DFA and CA-DFA were used in this study. Of these, 82 (43%) were
from hospitalized subjects and 108 (57%) were from outpatients. The majority of
specimens (n  180; 95%) were from children younger than 12 years of age
(average age, 3.7 years).
Viral RNA was extracted from 0.2 ml of each specimen by using the High Pure
Viral Nucleic Acid kit (Roche Diagnostics), according to the instructions of the
manufacturer. Purified specimen RNA was eluted from the column in 50 l of
elution buffer (Roche Diagnostics) and stored at 70°C until analysis. RNA
extracts were used in both the LC-RT-PCR and the conventional RT-PCR,
which were performed with the investigators blinded to the DFA and CA-DFA
results.
LC-RT-PCR.The LightCycler instrument provides a platform for the amplifi-
cation of target nucleic acid and monitors the development of amplification
reaction products by fluorescence after the annealing step in each cycle. This
technique is based on the FRET principle and was performed with two target-
specific hybridization probes that bind to adjacent positions on the target DNA.
The upstream oligonucleotide probe (probe RSV-LC1) was labeled with a donor
fluorophore, fluorescein, at the 3 terminus; and the downstream oligonucleotide
probe (probe RSV-LC2) was labeled with an acceptor fluorophore, LC-Red640,
at the 5 terminus (TIB-MOLBIOL, Berlin, Germany). Probe RSV-LC2 was also
phosphorylated at the 3 terminus to prevent extension by Taq DNA polymerase
during the amplification reaction (Table 1). The primers used in the LC-RT-PCR
(primers RSV-LCs and RSV-LCas; Table 1) targeted a sequence of the L gene
that was conserved across hRSV types A and B and that produced a 170-bp
product during the reaction.
The LightCycler RNA amplification kit for hybridization probes (Roche Di-
agnostics) was used as the basis for the reaction mixture in the LC-RT-PCR, with
a 20-l volume used in each reaction capillary. Briefly, the capillaries were
loaded with 0.4 l of the LC-RT-PCR enzyme mix (reagent 1; Roche Diagnos-
tics), 4.0 l of the LC-RT-PCR mix hybridization probes (reagent 2; Roche
Diagnostics), 2.4 l of MgCl2 stock solution (25 mM; reagent 3; Roche Diag-
nostics), 4.0 pmol of primer RSV-LCs, 8.0 pmol of primer RSV-LCas, 4.0 pmol
of probe RSV-LC1, 4.0 pmol of probe RSV-LC2, and 2 l of target RNA extract.
Each reaction volume was made up to 20 l with sterile PCR-grade water
(reagent 4; Roche Diagnostics). Every test run included a positive control and
three no-target controls consisting of 18 l of the reaction mixture with 2 l of
unrelated RNA. Reaction capillaries were capped, centrifuged, and placed into
the LightCycler carousel. Amplification and detection of amplified DNA were
performed by using the following parameters: an initial 25 min of incubation at
55°C for reverse transcription, followed by a denaturation step at 95°C for 30 s.
This was followed by 55 cycles of denaturation at 95°C for 5 s, primer and probe
annealing at 55°C for 15 s, and extension at 72°C for 25 s. The fluorescence
response data were obtained during the annealing period and displayed with the
channel setting F2/F1. The fluorescence gain settings were set to 1 for channel F1
and 15 for channel F2. Channel F3 was not used in the analysis of the sample
data.
LightCycler melting curve analysis. The LightCycler hybridization probes
were designed to be homologous to a highly conserved region of the L gene of
hRSV types A and B. This homology could be confirmed by fluorescent melting
curve analysis, which was performed with LightCycler software following the
completion of LC-PCR amplification. Briefly, the fluorescence was continuously
monitored as the capillaries were heated at a rate of 0.3°C/s, with the heating
started at 55°C and going to a final temperature of 95°C. The hybridization
probes were designed to dissociate from the amplification product of either
hRSV type at a temperature of approximately 62°C, which was calculated by
using Primer Premier (version 5.0; Premier Biosoft International, Palo Alto,
Calif.). If mutated amplification products were present, they would show a
reduction in melting temperature of more than 1°C.
Specificity of LC-RT-PCR. A panel of respiratory viruses and bacteria com-
monly found in the respiratory tract was used to determine the specificity of the
LC-RT-PCR. Genomic nucleic acid was purified from cultures of influenza virus
types A and B; adenovirus type 2; parainfluenza virus types 1, 2, and 3; Bordetella
bronchiseptica; Bordetella parapertussis; Bordetella pertussis; Burkholderia cepacia;
Chlamydia pneumoniae; Haemophilus influenzae; Klebsiella pneumoniae; Legio-
nella pneumophila; Mycoplasma pneumoniae; Pseudomonas aeruginosa; Staphylo-
coccus aureus; and Streptococcus pneumoniae and tested by the LC-RT-PCR
under the conditions described above.
Sensitivity of LC-RT-PCR. The limit of sensitivity of the LC-RT-PCR was
determined by testing dilutions of an hRSV culture representing a range of viral
titers. The number of PFU per milliliter in a culture of an hRSV type A isolate
was determined by standard laboratory methods (3, 14, 27). Serial 10-fold dilu-
tions of this isolate ranging from 5  106 to 5  101 PFU/ml were made. Viral
RNA was extracted from 0.2 ml of each dilution and tested by the LC-RT-PCR
under the conditions described above. The detection limit of the assay was
determined as the highest dilution that returned a positive reaction.
DFA. DFA was performed by standard laboratory methods (16, 21, 22).
Briefly, substrate slides were prepared from epithelial cells contained within the
NPA specimen, dried, and fixed in acetone for 10 min. Each well was incubated
with 30 l of each monoclonal antibody to the seven common respiratory viruses
(hRSV; influenza virus types A and B; parainfluenza virus types 1, 2, and 3; and
adenovirus) and stained with anti-mouse fluorescein isothiocyanate conjugate
(Intracel Corporation, Frederick, Md.). The cells in each well were examined for
fluorescence with an epifluorescence microscope (Olympus BX60; Olympus Op-
tical Co. Ltd., Tokyo, Japan) at a magnification of 400.
CA-DFA. CA-DFA was developed in our laboratory as a modification of the
standard shell vial technique (11; M. W. Syrmis et al., submitted for publication)
with 96-well microtitration plates (Nunc, Roskilde, Denmark). Four continuous
cell lines, MRC-5, A549, HEP-2, and LLC-MK2 (Biowhittaker, Walkersville,
Md.), which are permissive to infection with respiratory viruses, including hRSV,
were cultured in wells of the microtitration plates. Eighty microliters of each
NPA specimen was centrifuged onto the cell monolayers at 4,000 rpm for 30 min
at 35°C by using a Hettich Rotanta 96R microtitration plate centrifuge (Hettich
Zentrifugen, Tuttingen, Germany). The supernatants were aspirated from each
well and replaced with 200 l of maintenance medium (Eagle’s minimum essen-
tial medium; Biowhittaker) containing 2% (vol/vol) fetal bovine serum (Trace
Scientific, Noble Park, Australia), 9.75 U of penicillin G (5,000 U/ml; CSL
Biosciences, Parkville, Australia), 10 g of streptomycin sulfate (5000 g/ml;
CSL Biosciences), and 0.25 g of amphotericin B (5 mg/ml; Apothecon, Prince-
ton, N.J.). After 40 h of incubation at 37°C in a 5% CO2 atmosphere, the wells
were aspirated and the cell monolayers were fixed with an acetone-methanol
mixture (1:1; vol/vol) for 10 min at 20°C. The cell monolayers in the wells were
dried and overlaid with 30 l of appropriate monoclonal antibody (Intracel
Corporation) specific for the target respiratory viruses as described above for the
DFA method. After incubation with anti-mouse fluorescein isothiocyanate con-
jugate (Intracel Corporation), respiratory virus was identified with an inverted
fluorescent microscope (Eclipse TE200; Nikon, Tokyo, Japan) at a magnification
of 100.
TABLE 1. Primers and probes used in this study
Designation Sequence (5 to 3) Target gene Positiona Reference
Primers
RSV-LCs TCTTCATCACCATACTTTTCTGTTA L 12647–12623 This study
RSV-LCas GCCAAAAAATTGTTTCCACAATA L 12478–12500 This study
RSVN3 GGGAGAGGTGGCTCCAGAATACAGGC N 19
RSVN5 AGCATCACTTGCCCTGAACCATAGGC N 19
Probes
RSV-A Biotin-TTACAAAGGCTTACTACCCAAGGAC N 19
RSV-B Biotin-CTACAAGGGCCTCATACCAAAGGAT N 19
RSV-LC1 GTTGTTCTATAAGCTGGTATTGATGCA-fluoroscein L 12584–12558 This study
RSV-LC2 LC-Red640-GGAATTCACATGGTCTACTACTGACTGT-phosphate L 12556–12529 This study
a Position refers to the specific nucleotide locations of the primers and probes in the gene coding for the L protein of hRSV (GenBank accession number AF013254).










Conventional RT-PCR. The conventional hRSV RT-PCR assay targeted the N
gene of the hRSV genome (primers RSVN3 and RSVN5; Table 1) and was
described previously (19). We performed this assay in 0.2-ml thin-walled PCR
tubes in a model 2400 thermal cycler (Perkin-Elmer Applied Biosystems, Nor-
walk, Conn.) using the reagents and reaction conditions described by the original
investigators (19). All 190 specimens were tested by this assay, and this method
was used to determine the type of hRSV isolate detected by LC-RT-PCR, DFA,
or CA-DFA.
Conventional PCR amplicon detection. An enzyme-linked amplicon hybrid-
ization assay developed in our laboratory was used for amplicon detection (15).
This method used a hybridization reaction with two 5 biotinylated oligonucle-
otide probes specific for either hRSV type A or hRSV type B (RSV-A and
RSV-B, respectively; Invitrogen) (Table 1). Briefly, following amplification, the
reaction mixture was added to specific probes diluted in 1 SSC (0.15 M NaCl
plus 0.015 M sodium citrate) and denatured at 94°C. Following denaturation, the
contents of the tubes were incubated in streptavidin-coated microwells (Lab-
systems, Helsinki, Finland), washed, and further incubated with anti-digoxigenin
peroxidase conjugate (Roche Diagnostics). The wells were again washed, and
tetramethylbenzidine substrate (Moss Inc., Pasadena, Md.) was added to each
well. Color development was stopped by the addition of 100 l of 1 M HCl. The
optical density was recorded with a plate spectrophotometer (Murex, Dynex
Technology, Channel Islands, Great Britain) at a wavelength of 450 nm, with a
wavelength of 690 nm used as a reference. An optical density of 0.2 or greater
was indicative of a positive result.
RESULTS
A total of 190 NPA samples from patients with suspected
respiratory tract infections were tested by LC-RT-PCR, con-
ventional RT-PCR, and the DFA and CA-DFA testing algo-
rithm. The DFA and CA-DFA testing algorithm consisted of
initial screening of the specimens by DFA and then testing of
DFA-negative specimens by CA-DFA. In total, 77 (41%) spec-
imens were positive by LC-RT-PCR and conventional RT-
PCR, 75 (39%) were positive by the combination of DFA and
CA-DFA, and 113 (59%) specimens were negative by all four
methods. All 75 specimens that tested positive by use of the
DFA and CA-DFA testing algorithm tested positive by the
LC-RT-PCR and conventional RT-PCR. Two specimens that
were negative by DFA and CA-DFA were positive by the
LC-RT-PCR and the conventional RT-PCR method targeting
a different gene (N protein). The positive reactions obtained by
the conventional PCR for these specimens confirmed the pres-
ence of hRSV RNA, and it was shown that both of the spec-
imens contained hRSV type A. Typing of the remaining 75
hRSV isolates identified by the study showed that they con-
sisted of 65 hRSV type A isolates and 10 hRSV type B isolates.
Of the 75 positive specimens in which hRSV was identified
by DFA or CA-DFA, the initial DFA screen identified 70
(93%) positive samples, and subsequent testing by CA-DFA
identified 5 more positive samples. Compared to the results of
LC-RT-PCR, this gave the initial DFA screen a sensitivity of
91% and the DFA and CA-DFA testing algorithm a sensitivity
of 97%. There was complete agreement between the results of
the LC-RT-PCR and the conventional RT-PCR assays. The
limit of sensitivity of the LC-RT-PCR was determined by test-
ing dilutions of an hRSV type A isolate and was found to be 50
PFU/ml of specimen, which is equivalent to 0.25 PFU per
reaction mixture.
In the LC-RT-PCR quantification curve analysis, the thresh-
old cycle (CT) was the cycle number at which the sample’s
fluorescence curve became exponential. The CT values for
hRSV-positive specimens ranged from 17 to 36, reflecting a
range of concentrations of target RNA. The two specimens
that were LC-RT-PCR positive and DFA and CA-DFA neg-
ative showed CT values of 31 and 34, respectively, reflecting
low viral loads. Negative samples did not produce exponential
quantification curves during the PCR. Fluorescent melting
curve analysis by LC-RT-PCR of the 77 LC-RT-PCR-positive
specimens and the hRSV type A-positive and hRSV type B-
positive controls revealed melting temperatures ranging from
62 to 63°C. The fact that the melting temperatures varied by
only 1°C suggests that the hybridization probe targets are
highly conserved among the isolates identified by this study.
Testing of a panel of genetically unrelated viruses and bac-
teria commonly found in the respiratory tract failed to produce
any positive reaction, thus confirming the specificities of the
primers and probes used in the LC-RT-PCR.
DISCUSSION
Rapid laboratory diagnosis of hRSV infection in children
and infants can be critical for effective patient management by
focusing appropriate drug treatment, reducing unnecessary use
of antibiotics, and preventing nosocomial spread. This, com-
bined with an increasing awareness within the clinical commu-
nity of rapid PCR-based diagnostics, has led to greater pres-
sure for diagnostic laboratories to adopt molecular biology-
based diagnostic protocols. The LightCycler instrument is a
recently developed, commercially available nucleic acid ampli-
fication and detection system which enables PCR technology to
be easily incorporated into diagnostic laboratories. It is de-
signed to decrease the PCR assay time by monitoring the
amplification of target sequences in real time by FRET anal-
ysis. For our laboratory, the LightCycler instrument offered
significant benefits for the diagnosis of hRSV infections. First,
the LC-RT-PCR could generate results within 2 h of receipt of
the specimen, which was significantly faster than the minimum
time of 2 days required to complete the DFA and CA-DFA
testing algorithm.
Second, the LC-RT-PCR was more sensitive than the com-
bination of DFA and CA-DFA. Although the initial screen by
DFA could be performed within 3 h, it failed to detect hRSV
in seven specimens that were LC-RT-PCR positive. CA-DFA
detected hRSV in five of these specimens, leaving two speci-
mens negative by both tests. However, the presence of hRSV
RNA in these two specimens could be confirmed by a conven-
tional RT-PCR method targeting a gene on the hRSV genome
different from the gene targeted by the LC-RT-PCR. The
specificities of all methods were 100%, as no false-positive
results occurred with the clinical samples tested, and the LC-
RT-PCR failed to give a positive reaction in assays with any of
the unrelated organisms. In summary, in comparison to the
traditional DFA and CA-DFA assays, the LC-RT-PCR had a
faster turnaround time in terms of the time required to obtain
results, improved sensitivity, and equivalent specificity.
When designing the LC-RT-PCR we used the sequence data
in a publicly available sequence database (GenBank acces-
sion numbers AF254574, AF013255, AF013254, U63644,
AF035006, U50363, U50362, U27298, M74568, M75730,
U39661, U39662, and U35343) to identify primer and probe
sequences that would provide the optimal sensitivity and spec-
ificity for the assay. One of the critical factors for ensuring the
optimal sensitivity of any diagnostic PCR assay is the identifi-










cation of primer and probe sequences which are highly con-
served among the various isolates and types of the target or-
ganism. For hybridization probe assays, this is made more
difficult by the fact that the sequences of two primers and two
probes must be specific for genomic sequences in close prox-
imity (preferably within 200 bp) to allow maximum amplifica-
tion efficiency. One of the few conserved areas of the hRSV
genome that satisfied this requirement was the gene coding for
the L protein, and it was for this reason that we chose the L
gene as the target for our assay (13). In choosing this gene we
were conscious of the fact that limited sequence data are pub-
licly available for the hRSV L gene and that the transcription
rate of this gene is lower than those for genes located at the 3
end of the viral genome.
In practice, however, it was shown that the assay was very
sensitive, detecting 0.25 PFU of hRSV per reaction mixture, as
well as detecting hRSV in all samples that were positive by the
conventional RT-PCR assay. Other studies have also reported
increased sensitivities of PCR-based assays for the detection of
hRSV, with some showing a significant improvement over
DFA or culture-based methods (2, 10, 28). The LC-RT-PCR
described here showed a 9% improvement over DFA, which
was somewhat less than expected on the basis of the results of
the other studies. However, we believe that the sensitivity of
the LC-RT-PCR may have been limited by the use of the
one-step RT-PCR kit (LightCycler RNA amplification kit;
Roche Diagnostics). Previous experiments in our laboratory
have shown that RT-PCR assays that use these one-step re-
agents are less sensitive than assays that perform an initial step
of reverse transcription followed by a separate cDNA ampli-
fication step (data not shown).
Melting curve analysis showed that the sequences targeted
by the hybridization probes were well conserved across the
hRSV isolates detected. The melting temperatures of the 65
hRSV type A isolates and the 10 hRSV type B isolates varied
by only 1°C, ranging from 62 to 63°C. This suggests that false-
negative results are unlikely to occur as a result of sequence
variation.
In recent years, many PCR protocols for the detection of
infectious agents in the clinical diagnostic laboratory have been
described. The advent of real-time PCR has created further
potential to expand the use of PCR for disease diagnosis. The
LC-RT-PCR described here successfully detected hRSV RNA
in NPA specimens from patients with suspected respiratory
tract infections and therefore offers a suitable alternative to
conventional techniques for the detection of these infections.
The results showed that the LC-RT-PCR detected hRSV in all
specimens that were positive by DFA or CA-DFA, as well as in
seven additional DFA-negative specimens and two specimens
that were negative by both DFA and CA-DFA. This confirmed
that the LC-RT-PCR is more sensitive than DFA alone, as well
as the combined DFA and CA-DFA testing algorithm. In ad-
dition to improved sensitivity and a high degree of specificity,
we found that the LC-RT-PCR offered other significant ad-
vantages, including a faster turnaround time in terms of the
time required to obtain results and therefore greater cost-
effectiveness. The turnaround time for the LC-RT-PCR result
was approximately 2 h, which was marginally faster than that
for DFA (3 h) and a significant improvement over that for
CA-DFA (48 to 72 h). However, DFA can identify multiple
viral pathogens in a single test and is relatively cheap to per-
form. Therefore, in laboratories in which DFA might remain
the first test choice, LC-RT-PCR may provide a suitable alter-
native to cell culture-based assays.
A significant improvement of the LC-RT-PCR over conven-
tional viral detection methods may be in the detection of hRSV
infection in older children and adults, particularly in cases of
reinfection. In these subjects the productive viral load during
infection is significantly reduced and disease is more difficult to
diagnose by DFA and culture-based assays. This was supported
by the results of this study, which showed that six of the seven
specimens that were DFA negative and LC-RT-PCR positive
were from subjects older than 12 years of age. In addition, the
two LC-RT-PCR-positive specimens that were DFA and CA-
DFA negative were collected from adults (ages, 20 and 31
years). These results suggest that the improved sensitivity of
the LC-RT-PCR becomes significant in the diagnosis of hRSV
infections in older subjects with low viral loads. In addition, the
failure of DFA and CA-DFA to detect virus in a clinical spec-
imen might be due to the presence of nonviable virions in the
sample as a result of either an insufficient amount of specimen
or the use of inappropriate transport or storage conditions (8).
The LC-RT-PCR is not affected by these limitations and relies
on the presence of viral nucleic acid rather than viable or intact
virions (17, 19).
Although the hRSV LC-RT-PCR described here presents
several advantages over conventional viral detection methods,
it is limited by its ability to detect a single target only. We are
examining the LightCycler technology with a view to develop-
ing duplex and multiplex real-time PCR assays for the detec-
tion of multiple respiratory viruses in a single reaction. These
assays will offer a significant improvement over existing virus
detection methods and should receive a wider application in
the routine clinical laboratory.
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